Financials
- Market Capitalization 17.8 M
- Employee 142
- Founded 2001
- CEO Yaky Yanay
- Website www.pluri-biotech.com
- Headquarter Nevada, United States
- FIGI BBG000DQX509
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-1.39
Fiyat/satışlar oranı
23.48
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 4643 | JSPR Jasper Therapeutics, Inc. - Class A Common Stock | 0.68 USD | +11.48% | +47.83% | +51.11% | -80.57% | 19.04 M USD | ||
| 4646 | NCEL NewcelX Ltd. - Ordinary Shares | 3.92 USD | -2.00% | 0.00% | +18.79% | -22.83% | 18.81 M USD | ||
| 4686 | PTN Palatin Technologies, Inc. Common Stock | 9.32 USD | -2.10% | -15.96% | -33.48% | +28.55% | 16.58 M USD | ||
| 4687 | HOWL Werewolf Therapeutics, Inc. - Common Stock | 0.34 USD | 0.00% | 0.00% | -10.53% | -73.85% | 16.52 M USD |